Bet v 1 - a Trojan horse for small ligands boosting allergic sensitization?

Clinical and Experimental Allergy

Volumn 44, Issue 8, 2014, Pages 1083-1093

  Asam, C ^a   Batista, A L ^b   Moraes, A H ^b   de Paula, V S ^b   Almeida, F C L ^b   Aglas, L ^a   Kitzmuller C ^c   Bohle, B ^c   Ebner, C ^d   Ferreira, F ^a   Wallner, M ^a   Valente, A P ^b  

^a UNIVERSITY OF SALZBURG   (Austria)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d Allergie Ambulatorium Rennweg Vienna   (Austria)

Author keywords

Allergenicity; Allergic sensitization; Bet v 1; Epitope mapping; Human IgE epitope; IgE reactivity; NMR

Indexed keywords

BET V 1 PROTEIN; DEOXYCHOLATE SODIUM; DEOXYCHOLIC ACID; IMMUNOGLOBULIN E; POLLEN ANTIGEN; UNCLASSIFIED DRUG; ALLERGEN; EPITOPE; LIGAND; PLANT ANTIGEN; PROTEIN BINDING; RECOMBINANT PROTEIN;

ALLERGENICITY; ANIMAL EXPERIMENT; ARTICLE; BASOPHIL; BASOPHIL DEGRANULATION; CELL ACTIVATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; IMMUNOGENICITY; MEDIATOR RELEASE; MOUSE; NITROGEN NUCLEAR MAGNETIC RESONANCE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIZATION; THERMOSTABILITY; ADVERSE EFFECTS; ANIMAL; BASOPHIL DEGRANULATION TEST; BIRCH; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; DEGRANULATION; DISEASE MODEL; EPITOPE MAPPING; HAY FEVER; IMMUNIZATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; POLLEN; PROTEIN CONFORMATION; PROTEIN STABILITY; THERMODYNAMICS;

ALLERGENS; ANIMALS; ANTIGENS, PLANT; BASOPHIL DEGRANULATION TEST; BASOPHILS; BETULA; CELL DEGRANULATION; CELL LINE; DEOXYCHOLIC ACID; DISEASE MODELS, ANIMAL; EPITOPE MAPPING; EPITOPES; FEMALE; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN E; LIGANDS; MICE; MODELS, MOLECULAR; POLLEN; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STABILITY; RECOMBINANT PROTEINS; RHINITIS, ALLERGIC, SEASONAL; THERMODYNAMICS;

EID: 84904662011     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12361     Document Type: Article

References (23)

1. Wills-Karp M, Nathan A, Page K, Karp CL. New insights into innate immune mechanisms underlying allergenicity. Mucosal Immunol 2010; 3:104-10.
2. Karp CL. Guilt by intimate association: what makes an allergen an allergen? J Allergy Clin Immunol 2010; 125:955-60; quiz 61-2.
3. Gieras A, Cejka P, Blatt K et al. Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1. J Immunol 2011; 186:5333-44.
4. Erler A, Hawranek T, Kruckemeier L et al. Proteomic profiling of birch (Betula verrucosa) pollen extracts from different origins. Proteomics 2011; 11:1486-98.
5. Kofler S, Asam C, Eckhard U, Wallner M, Ferreira F, Brandstetter H. Crystallographically mapped ligand binding differs in high and low IgE binding isoforms of birch pollen allergen bet v 1. J Mol Biol 2012; 422:109-23.
6. Hauser M, Asam C, Himly M et al. Bet v 1-like pollen allergens of multiple Fagales species can sensitize atopic individuals. Clin Exp Allergy 2011; 41:1804-14.
7. Runswick S, Mitchell T, Davies P, Robinson C, Garrod DR. Pollen proteolytic enzymes degrade tight junctions. Respirology 2007; 12:834-42.
8. Traidl-Hoffmann C, Mariani V, Hochrein H et al. Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization. J Exp Med 2005; 201:627-36.
9. Gilles S, Fekete A, Zhang X et al. Pollen metabolome analysis reveals adenosine as a major regulator of dendritic cell-primed T(H) cell responses. J Allergy Clin Immunol 2011; 127:454-61 e1-9.
10. Seutter von Loetzen C, Hoffmann T, Hartl MJ et al. Secret of the major birch pollen allergen Bet v 1: identification of the physiological ligand. Biochem J 2014; 457:379-90.
11. Markovic-Housley Z, Degano M, Lamba D et al. Crystal structure of a hypoallergenic isoform of the major birch pollen allergen Bet v 1 and its likely biological function as a plant steroid carrier. J Mol Biol 2003; 325:123-33.
12. Koistinen KM, Soininen P, Venäläinen TA et al. Birch PR-10c interacts with several biologically important ligands. Phytochemistry 2005; 66:2524-33.
13. Wallner M, Hauser M, Himly M et al. Reshaping the Bet v 1 fold modulates T(H) polarization. J Allergy Clin Immunol 2011; 127:1571-8 e9.
14. Razzera G, Gadermaier G, de Paula V et al. Mapping the interactions between a major pollen allergen and human IgE antibodies. Structure 2010; 18:1011-21.
15. Vogel L, Luttkopf D, Hatahet L, Haustein D, Vieths S. Development of a functional in vitro assay as a novel tool for the standardization of allergen extracts in the human system. Allergy 2005; 60:1021-8.
16. Egger M, Jurets A, Wallner M et al. Assessing protein immunogenicity with a dendritic cell line-derived endolysosomal degradome. PLoS One 2011; 6:e17278.
17. Ohkuri T, Nagatomo S, Oda K, So T, Imoto T, Ueda T. A protein's conformational stability is an immunologically dominant factor: evidence that free-energy barriers for protein unfolding limit the immunogenicity of foreign proteins. J Immunol 2010; 185:4199-205.
18. So T, Ito H, Hirata M, Ueda T, Imoto T. Contribution of conformational stability of hen lysozyme to induction of type 2 T-helper immune responses. Immunology 2001; 104:259-68.
19. Thomas WR, Hales BJ, Smith WA. Structural biology of allergens. Curr Allergy Asthma Rep 2005; 5:388-93.
20. Trompette A, Divanovic S, Visintin A et al. Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 2009; 457:585-8.
21. Spangfort MD, Mirza O, Ipsen H, Van Neerven RJ, Gajhede M, Larsen JN. Dominating IgE-binding epitope of Bet v 1, the major allergen of birch pollen, characterized by X-ray crystallography and site-directed mutagenesis. J Immunol 2003; 171:3084-90.
22. Mirza O, Henriksen A, Ipsen H et al. Dominant epitopes and allergic cross-reactivity: complex formation between a Fab fragment of a monoclonal murine IgG antibody and the major allergen from birch pollen Bet v 1. J Immunol 2000; 165:331-8.
23. Ferreira F, Ebner C, Kramer B et al. Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy. FASEB J 1998; 12:231-42.